Pediatric Cancer

PEDIATRIC CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Children With Cancer Not Experiencing as Severe COVID-19 as Initially Feared

Studies suggest that the majority of pediatric patients with cancer and COVID-19 experience mild disease — rather than severe disease — as a result of infection with the novel virus.
Does Larotrectinib Offer New Hope to Children With TRK Fusion-Positive Solid Tumors?

Because of the drug’s promising safety and efficacy, the first child was treated on trial only 9 months after the first adult with a TRK fusion was treated.
Recent Conference Highlights New Potential Targets for Pediatric Cancer Treatments

Advances in targeted therapy for pediatric patients were presented at the AACR Special Conference on Pediatric Cancer.

PEDIATRIC CANCER NEWS

pediatrician and parent talk about patient

Increased Mortality Risk in Patients With Cancer Experiencing the Death of a Child

November 30, 2020

In this study, a young adult was defined as an individual who was 40 years or younger.

Evolving Incidence Trends in AYA Cancers

November 25, 2020

Glioma

Role Exists for Re-Irradiation of Older Patients with Recurrent Glioma

November 10, 2020

While survival rates of pediatric patients with cancer are greatly improved, researchers and clinici

ctDNA Methylation May Identify Pediatric Medulloblastoma

November 9, 2020

While survival rates of pediatric patients with cancer are greatly improved, researchers and clinici

Extensive Molecular Characterization Uncovers Actionable Alterations in Many High-Risk Pediatric Cancers

October 29, 2020

Next post in Pediatric Cancer

In this study, a young adult was defined as an individual who was 40 years or younger.

Evolving Incidence Trends in AYA Cancers